ZA744703B - Corticosteroid phosphate salts/ neomycin sulfate ophtalmic solution - Google Patents

Corticosteroid phosphate salts/ neomycin sulfate ophtalmic solution

Info

Publication number
ZA744703B
ZA744703B ZA00744703A ZA744703A ZA744703B ZA 744703 B ZA744703 B ZA 744703B ZA 00744703 A ZA00744703 A ZA 00744703A ZA 744703 A ZA744703 A ZA 744703A ZA 744703 B ZA744703 B ZA 744703B
Authority
ZA
South Africa
Prior art keywords
corticosteroid
phosphate salts
neomycin sulfate
ophtalmic
solution
Prior art date
Application number
ZA00744703A
Other languages
English (en)
Inventor
J Mcginity
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA744703B publication Critical patent/ZA744703B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA00744703A 1973-08-01 1974-07-23 Corticosteroid phosphate salts/ neomycin sulfate ophtalmic solution ZA744703B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US384551A US3898330A (en) 1973-08-01 1973-08-01 Corticosteroid phosphate salts/neomycin sulfate ophthalmic

Publications (1)

Publication Number Publication Date
ZA744703B true ZA744703B (en) 1975-07-30

Family

ID=23517768

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00744703A ZA744703B (en) 1973-08-01 1974-07-23 Corticosteroid phosphate salts/ neomycin sulfate ophtalmic solution

Country Status (12)

Country Link
US (1) US3898330A (https=)
JP (1) JPS5042026A (https=)
BE (1) BE818410A (https=)
CA (1) CA1031262A (https=)
DE (1) DE2437145A1 (https=)
DK (1) DK134924B (https=)
FR (1) FR2240013B1 (https=)
GB (1) GB1471326A (https=)
NL (1) NL7410297A (https=)
NO (1) NO141394C (https=)
SE (1) SE7409891L (https=)
ZA (1) ZA744703B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
EP0037043B1 (en) * 1980-03-21 1984-11-21 The Wellcome Foundation Limited Stabilised ophthalmic formulation
US5883074A (en) * 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
US6843983B2 (en) * 2001-06-07 2005-01-18 Virgie Bright-Ellington Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
CA2615173C (en) 2005-07-14 2012-01-03 Lipothera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ,インク. 甲状腺眼症の治療のための方法、組成物及び製剤
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
UA111822C2 (uk) 2010-11-24 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Новамедіка" Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105795A (en) * 1957-02-12 1963-10-01 Schering Corp 9alpha-fluoro-15beta-hydroxy-1, 4-pregnadienes and pharmaceutical preparations containing same
US3146164A (en) * 1960-08-09 1964-08-25 Merck & Co Inc Solutions of steroid phosphate and basic antibiotics stabilized with creatinine
US3138528A (en) * 1962-05-01 1964-06-23 Olin Mathieson Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides

Also Published As

Publication number Publication date
JPS5042026A (https=) 1975-04-16
AU7159874A (en) 1976-01-29
DK409774A (https=) 1975-04-01
CA1031262A (en) 1978-05-16
NO742767L (https=) 1975-03-03
BE818410A (fr) 1975-02-03
DK134924C (https=) 1977-08-01
NO141394C (no) 1980-03-05
US3898330A (en) 1975-08-05
FR2240013A1 (https=) 1975-03-07
SE7409891L (https=) 1975-02-03
DE2437145A1 (de) 1975-02-13
DK134924B (da) 1977-02-14
NO141394B (no) 1979-11-26
NL7410297A (nl) 1975-02-04
FR2240013B1 (https=) 1977-11-04
GB1471326A (en) 1977-04-21

Similar Documents

Publication Publication Date Title
CA1021285A (en) Reusable shields for selective electrodeposition
CA928445A (en) Continuous process for preparing noncellular polyurethanes
AU6994974A (en) Structural members
ZA74349B (en) Plate dialyzer
IL45988A0 (en) Demand pacer
HK980A (en) Trh l-lartrate crystals
ZA744703B (en) Corticosteroid phosphate salts/ neomycin sulfate ophtalmic solution
AU6939974A (en) Sulphamoylbenzoic acid
GB1485150A (en) Pilo-carpine salt
ZA74492B (en) Diakyl thionocarbamate method
ZA747189B (en) Antistatic surfaces
IL44613A0 (en) New pregnane acid derivatives
IL43881A0 (en) New pregnane 21-carboxylic acid derivatives
AU7504374A (en) For making structural members
ZA739656B (en) New pregnane acid derivatives
AU483525B2 (en) Corticosteroid phosphate salts neomycin sulfate ophthalmic solution
AU7139574A (en) Fasteners
GB1483379A (en) 7-halo-methyl-17-hydroxy-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid ypsilon-lactones
ZA745326B (en) Antibacterial agents
AU6566674A (en) Beta-pyridyl-carbonamido-alkane-sulfonic acid salts
JPS5069090A (en) Shinki na maruchiheterokyodaikankagobutsu no seiho
ZA742355B (en) New pregnane acid derivatives
AU6292073A (en) Additive for electrodeposition
CA812255A (en) Dithiophosphoric acid salts
ZA742437B (en) Mono- and dialkylated prostynoic acid derivatives